Css LLC Novavax Inc Put Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.71 - $17.11 $26,775 - $42,775
2,500 Added 1.44%
176,100 $2.22 Million
Q2 2024

Aug 14, 2024
SELL
$3.89 - $20.97 $93,360 - $503,280
-24,000 Reduced 12.15%
173,600 $2.2 Million
Q1 2024

May 15, 2024
SELL
$3.76 - $6.02 $131,600 - $210,699
-35,000 Reduced 15.05%
197,600 $944,000
Q4 2023

Feb 14, 2024
BUY
$4.8 - $7.67 $132,000 - $210,925
27,500 Added 13.41%
232,600 $1.12 Million
Q3 2023

Nov 14, 2023
SELL
$6.81 - $9.74 $136,200 - $194,800
-20,000 Reduced 8.88%
205,100 $1.48 Million
Q2 2023

Aug 14, 2023
BUY
$6.67 - $9.52 $1 Million - $1.43 Million
150,100 Added 200.13%
225,100 $1.67 Million
Q1 2023

May 15, 2023
SELL
$5.76 - $12.48 $89,856 - $194,688
-15,600 Reduced 17.22%
75,000 $519,000
Q4 2022

Feb 14, 2023
BUY
$8.86 - $25.04 $428,824 - $1.21 Million
48,400 Added 114.69%
90,600 $931,000
Q3 2022

Nov 14, 2022
SELL
$18.2 - $76.12 $662,480 - $2.77 Million
-36,400 Reduced 46.31%
42,200 $767,000
Q2 2022

Aug 15, 2022
BUY
$36.28 - $75.29 $2.66 Million - $5.53 Million
73,400 Added 1411.54%
78,600 $4.04 Million
Q1 2022

May 16, 2022
SELL
$69.73 - $142.9 $7.54 Million - $15.5 Million
-108,200 Reduced 95.41%
5,200 $382,000
Q4 2021

Feb 14, 2022
SELL
$134.56 - $217.97 $672,800 - $1.09 Million
-5,000 Reduced 4.22%
113,400 $16.2 Million
Q3 2021

Nov 15, 2021
SELL
$177.8 - $270.58 $906,780 - $1.38 Million
-5,100 Reduced 4.13%
118,400 $24.5 Million
Q2 2021

Aug 16, 2021
BUY
$121.0 - $257.67 $399,300 - $850,311
3,300 Added 2.75%
123,500 $26.2 Million
Q1 2021

May 17, 2021
SELL
$112.98 - $319.93 $3.43 Million - $9.73 Million
-30,400 Reduced 20.19%
120,200 $21.8 Million
Q4 2020

Feb 16, 2021
BUY
$78.74 - $139.5 $1.27 Million - $2.25 Million
16,100 Added 11.97%
150,600 $16.8 Million
Q3 2020

Nov 16, 2020
BUY
$79.44 - $178.51 $3.56 Million - $8 Million
44,800 Added 49.94%
134,500 $14.6 Million
Q2 2020

Aug 14, 2020
BUY
$13.86 - $83.61 $1.24 Million - $7.5 Million
89,700 New
89,700 $7.48 Million

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email